Genelux receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genelux Corp (GNLX)
Genelux Corp stock price live, this page displays NASDAQ GNLX stock exchange data. View the GNLX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genelux Corp real time stock price chart below.
What Is the Genelux Corp Stock Price Today?
The Genelux Corp stock price today is 2.390.
What Is the Stock Symbol for Genelux Corp?
The stock symbol for Genelux Corp is "GNLX."
What Stock Exchange Does Genelux Corp Trade On?
Genelux Corp is listed and trades on the NASDAQ stock exchange.
Is Genelux Corp a Good Stock to Buy?
Determining whether Genelux Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNLX quote. (ISIN: US36870H1032)
What Is the Genelux Corp Stock Price Today?
The Genelux Corp stock price today is 2.390.
What Is the Stock Symbol for Genelux Corp?
The stock symbol for Genelux Corp is "GNLX."
What Stock Exchange Does Genelux Corp Trade On?
Genelux Corp is listed and trades on the NASDAQ stock exchange.
Is Genelux Corp a Good Stock to Buy?
Determining whether Genelux Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNLX quote. (ISIN: US36870H1032)
NASDAQ
Currency in USD
2.390
-0.150(-5.91%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.330
2.495
52 wk Range
1.988
8.535
GNLX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.3302.495
52 wk Range
1.9888.535
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GNLX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
18.000
Upside
+653.14%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 424B5 Genelux Corp For: 19 March
- Investing.com
- Form 424B5 Genelux Corp For: 7 January
- Investing.com
- Form 8K Genelux Corp For: 2 February
- Investing.com
- Genelux receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 424B5 Genelux Corp For: 19 March
- Investing.com
- Form 8K Genelux Corp For: 2 February
- Investing.com
- Form 424B5 Genelux Corp For: 8 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. It also offers CHOICE, a technology and discovery and development platform; and developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Compare GNLX to Peers and Sector
Metrics to compare | GNLX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGNLXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.5x | −4.1x | −0.5x | |
PEG Ratio | −0.56 | 0.15 | 0.00 | |
Price/Book | 6.1x | 2.8x | 2.6x | |
Price / LTM Sales | - | 28.2x | 3.1x | |
Upside (Analyst Target) | - | 247.7% | 55.6% | |
Fair Value Upside | Unlock | −1.7% | 8.6% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.000
(+653.14% Upside)
Earnings
Latest Release
Mar 19, 2026
EPS / Forecast
-0.24 / -0.22
Revenue / Forecast
8K / --
People Also Watch
FAQ
What Is the Genelux (GNLX) Stock Price Today?
The Genelux stock price today is 2.390 USD.
What Stock Exchange Does Genelux Trade On?
Genelux is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Genelux?
The stock symbol for Genelux is "GNLX."
What Is the Genelux Market Cap?
As of today, Genelux market cap is 112.480M USD.
What Is Genelux's Earnings Per Share (TTM)?
The Genelux EPS (TTM) is -0.878.
When Is the Next Genelux Earnings Date?
Genelux will release its next earnings report on May 13, 2026.
From a Technical Analysis Perspective, Is GNLX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Genelux Stock Split?
Genelux has split 0 times.
How Many Employees Does Genelux Have?
Genelux has 24 employees.
What is the current trading status of Genelux (GNLX)?
As of Mar 20, 2026, Genelux (GNLX) is trading at a price of 2.390 USD, with a previous close of 2.540 USD. The stock has fluctuated within a day range of 2.330 USD to 2.495 USD, while its 52-week range spans from 1.988 USD to 8.535 USD.
What Is Genelux (GNLX) Price Target According to Analysts?
The average 12-month price target for Genelux is 18.000 USD, with a high estimate of 31 USD and a low estimate of 10 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +653.14% Upside potential.
What Is the GNLX Premarket Price?
GNLX's last pre-market stock price is 2.400 USD. The pre-market share volume is 1,290.000, and the stock has decreased by -0.140, or -5.510%.
What Is the GNLX After Hours Price?
GNLX's last after hours stock price is 2.720 USD, the stock has decreased by 0.180, or 7.090%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.